GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (FRA:GU5) » Definitions » Market Cap

Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) Market Cap : €5,942 Mil (As of Dec. 13, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Guangzhou Baiyunshan Pharmaceutical Holdings Co's share price for the quarter that ended in Sep. 2024 was €2.26. Guangzhou Baiyunshan Pharmaceutical Holdings Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 1,626 Mil. Therefore, Guangzhou Baiyunshan Pharmaceutical Holdings Co's market cap for the quarter that ended in Sep. 2024 was €3,674 Mil.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's quarterly market cap increased from Mar. 2024 (€3,577 Mil) to Jun. 2024 (€3,837 Mil) but then declined from Jun. 2024 (€3,837 Mil) to Sep. 2024 (€3,674 Mil).

Guangzhou Baiyunshan Pharmaceutical Holdings Co's annual market cap increased from Dec. 2021 (€3,739 Mil) to Dec. 2022 (€4,292 Mil) but then declined from Dec. 2022 (€4,292 Mil) to Dec. 2023 (€3,902 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Guangzhou Baiyunshan Pharmaceutical Holdings Co's Enterprise Value for Today is €5,524 Mil.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Market Cap Historical Data

The historical data trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Market Cap Chart

Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,519.70 3,056.49 3,739.32 4,292.09 3,901.90

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,292.09 3,901.90 3,576.74 3,836.86 3,674.29

Competitive Comparison of Guangzhou Baiyunshan Pharmaceutical Holdings Co's Market Cap

For the Medical Distribution subindustry, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Baiyunshan Pharmaceutical Holdings Co's Market Cap Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Guangzhou Baiyunshan Pharmaceutical Holdings Co's Market Cap falls into.



Guangzhou Baiyunshan Pharmaceutical Holdings Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€2.4*1625.79
=€3,902

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=€2.26*1625.79
=€3,674

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangzhou Baiyunshan Pharmaceutical Holdings Co  (FRA:GU5) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Market Cap Related Terms

Thank you for viewing the detailed overview of Guangzhou Baiyunshan Pharmaceutical Holdings Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description

Traded in Other Exchanges
Address
89 Queensway, Room 2005, 20th Floor, Tower Two, Lippo Center, Hong Kong, HKG
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its segment includes Great Southern TCM; Great Health; Great Commerce and others. The company generates maximum revenue from the Great Commerce segment.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Headlines

No Headlines